In the present study, we found that both elevated serum MIC-1 concentrations before chemotherapy and increased serum MIC-1 concentrations during chemotherapy were independent prognostic factors of poor OS in patients with advanced GC, suggesting that MIC-1 might be a potential prognostic biomarker in these patients. The gene discussed is GDF15; the disease is gastric cancer.